Bristol-Myers Squibb Company's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how much money the company made and spent in the first half of 2026.
Company shared detailed results and business plans with investors and the public.
Investors voted on who leads the company and how much executives earn.
Shows how much money the company made and spent in the first three months of 2026.
Company shared detailed results and business plans with investors and the public.
Shows the company's total money, spending, and performance for all of 2025.
Company shared detailed annual results and business plans with investors and the public.
Stocky reads Bristol-Myers Squibb Company's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Bristol-Myers Squibb Company's most recent tracked filing was a 10-Q on 30 Jul 2026: Second quarter 2026 financial results announced July 30.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.